$NYMXF Market Cap:
Research Board Inbox Deep Research Not Interested Shortlisted

$NYMXF SEC Filings

Filing Filed On
POST EFFECTIVE AMENDMENT #2 15 May 2001
NYMOX PHARMACEUTICAL CORPORATION 08 May 2001
NYMOX PHARMACEUTICAL CORPORATION 08 May 2001
POST EFFECTIVE AMENDMENT NO. 1 08 May 2001
NYMOX PHARMACEUTICAL CORPORATION: PROS SUPPLEMENT 15 Feb 2001
NYMOX PHARMACEUTICAL CORPORATION 15 Dec 2000
NYMOX PHARMACEUTICAL CORPORATION 15 Nov 2000
PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED 3/9/00 12 Oct 2000
NYMOX PHARMACEUTICAL CORPORATION 22 Aug 2000
FORM 6-K 18 Aug 2000
NYMOX PHARMACEUTICAL CORPORATION 14 Aug 2000
AMENDMENT #1 TO FORM 6-K: NYMOX 19 May 2000
NYMOX PHARMACEUTICAL CORPORATION 15 May 2000
NYMOX PHARMACEUTICAL CORPORATION 15 May 2000
AMENDMENT NO. 1 TO FORM F-1 09 Mar 2000
NYMOX PHARMACEUTICAL CORPORATION 29 Feb 2000
NYMOX PHARMACEUTICAL CORPORATION 15 Nov 1999
NYMOX PHARMACEUTICAL CORPORATION 10 Aug 1999
NYMOX PHARMACEUTICAL CORPORATION 06 Aug 1999
NYMOX PHARMACEUTICAL CORPORATION 19 May 1999